GSK builds oncology pipeline as drug shown to help myeloma patients Reuters Aug 23, 2019 Two doses of belantamab mafodotin helped subdue disease in adults who received three prior treatments for multiple myeloma
New blockbuster drugs will push multiple myeloma treatment market to $22.4 bn by 2023 EP News Bureau Nov 20, 2015 The increase will be boosted by increasing therapeutic options, including the introduction of two monoclonal antibodies with…
